We are live on ! Find out more
KIA

Kopp Investment Advisors Portfolio holdings

AUM $54.4M
1-Year Est. Return 14.33%
This Fund
S&P 500
This Quarter Est. Return
+17.33%
1 Year Est. Return
+14.33%
3 Year Est. Return
+109.21%
5 Year Est. Return
+340.72%
10 Year Est. Return
–
AUM
$119M
AUM Growth
+$12.2M
Cap. Flow
-$2.05M
Cap. Flow %
-1.73%
Top 10 Hldgs %
45.53%
Holding
62
New
3
Increased
16
Reduced
34
Closed
4

Top Buys

Rank Stock Value
1
VCEL icon
Vericel Corp
VCEL
+$1.68M
2
CY
Cypress Semiconductor
CY
+$1.26M
3
HDP
Hortonworks, Inc.
HDP
+$689K
4
KTWO
K2M Group Holdings, Inc
KTWO
+$644K
5
ATRC icon
AtriCure
ATRC
+$247K

Top Sells

Rank Stock Value
1
EGHT icon
8x8 Inc
EGHT
+$2.81M
2
ARRY
Array Biopharma Inc
ARRY
+$1.14M
3
LGND icon
Ligand Pharmaceuticals
LGND
+$884K
4
OMCL icon
Omnicell
OMCL
+$430K
5
NEO icon
NeoGenomics
NEO
+$306K

Sector Composition

Rank Sector Weight
1 Healthcare 46.93%
2 Technology 37.18%
3 Financials 3.33%
4 Miscellaneous 2.81%
5 Industrials 2.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NEO icon
1
NeoGenomics
NEO
$2.39B
$6.37M 5.36%
414,833
-22,139
-5% -$306K
TWLO icon
2
Twilio
TWLO
$37.1B
$5.88M 4.95%
68,176
-949
-1% -$69.4K
IDTI
3
DELISTED
Integrated Device Technology I
IDTI
$5.85M 4.92%
124,480
-2,731
-2% -$106K
VCEL icon
4
Vericel Corp
VCEL
$2.11B
$5.66M 4.76%
400,048
+143,391
+56% +$1.68M
HDP
5
DELISTED
Hortonworks, Inc.
HDP
$5.43M 4.57%
238,013
+33,033
+16% +$689K
XENT
6
DELISTED
Intersect ENT, Inc
XENT
$5.36M 4.51%
186,561
-4,821
-3% -$145K
LGND icon
7
Ligand Pharmaceuticals
LGND
$5.67B
$5.35M 4.5%
31,222
-5,865
-16% -$884K
ATRC icon
8
AtriCure
ATRC
$2.51B
$5.05M 4.25%
144,268
+7,805
+6% +$247K
CY
9
DELISTED
Cypress Semiconductor
CY
$4.67M 3.93%
322,237
+76,753
+31% +$1.26M
OMCL icon
10
Omnicell
OMCL
$1.52B
$4.48M 3.77%
62,250
-6,827
-10% -$430K
KTWO
11
DELISTED
K2M Group Holdings, Inc
KTWO
$4.3M 3.62%
156,960
+27,485
+21% +$644K
SRGA
12
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$4.04M 3.4%
29,908
+973
+3% +$134K
CVLT icon
13
Commault Systems
CVLT
$5.82B
$3.96M 3.33%
56,512
-2,184
-4% -$148K
PODD icon
14
Insulet
PODD
$9.95B
$3.93M 3.31%
37,072
-2,337
-6% -$219K
CYBR
15
DELISTED
CyberArk
CYBR
$3.87M 3.26%
48,453
-1,651
-3% -$116K
IMPV
16
DELISTED
Imperva, Inc.
IMPV
$3.53M 2.97%
75,952
-1,043
-1% -$50.5K
OCLR
17
DELISTED
Oclaro Inc.
OCLR
$3.04M 2.56%
340,388
-12,602
-4% -$114K
TLGT
18
DELISTED
Teligent, Inc
TLGT
$2.86M 2.41%
72,358
-4,272
-6% -$171K
NXTM
19
DELISTED
NxStage Medical Inc.
NXTM
$2.76M 2.32%
98,865
-5,495
-5% -$155K
FNSR
20
DELISTED
Finisar Corp
FNSR
$2.65M 2.23%
138,993
-4,280
-3% -$79.6K
MXL icon
21
MaxLinear
MXL
$5.75B
$2.58M 2.17%
129,729
-4,539
-3% -$82.6K
SUPN icon
22
Supernus Pharmaceuticals
SUPN
$2.57B
$2.1M 1.77%
41,700
-179
-0.4% -$8.84K
HZNP
23
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.8M 1.52%
92,189
-1,031
-1% -$19.6K
AAPL icon
24
Apple
AAPL
$4.59T
$1.67M 1.4%
29,572
-520
-2% -$27.1K
SPY icon
25
State Street SPDR S&P 500 ETF Trust
SPY
$827B
$1.29M 1.09%
4,450
– –
1
2 3

Similar funds

OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
GX
Greylock XII Menlo Park, California $51.9M AUM 11.52% 1-Year Est. Return
PGA
Premia Global Advisors Coral Gables, Florida $57.9M AUM 2.91% 1-Year Est. Return
SCG
Saban Capital Group Los Angeles, California $59.5M AUM 3.83% 1-Year Est. Return
TCMV
Technology Crossover Management VI Menlo Park, California $59.6M AUM 18.81% 1-Year Est. Return
FCM
Farmstead Capital Management Ridgewood, New Jersey $49M AUM 10.57% 1-Year Est. Return
SAM
Sheffield Asset Management Chicago, Illinois $48.1M AUM 12.96% 1-Year Est. Return
ACP
Aquiline Capital Partners New York $46.9M AUM 5.65% 1-Year Est. Return

Kopp Investment Advisors's Q3 2018 Portfolio in Review

As of Q3 2018, Kopp Investment Advisors held 62 positions worth $119M, up 11% from $107M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Kopp Investment Advisors's Q3 2018 filing shows 3 new, 16 increased, 34 reduced and 4 closed positions. Its largest new stake was Pfizer: 6,126 shares worth $256K. The largest sale was 8x8 Inc, an estimated $2.81M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 47% a quarter earlier, followed by Technology and Financials.

  • Kopp Investment Advisors's largest Q3 2018 buy was Pfizer: 6,126 shares worth $256K.
  • Kopp Investment Advisors added most to Vericel Corp in Q3 2018, an estimated $1.68M increase.
  • Kopp Investment Advisors's biggest Q3 2018 reduction was Ligand Pharmaceuticals, cutting an estimated $884K.
  • Kopp Investment Advisors fully exited 8x8 Inc in Q3 2018, selling an estimated $2.81M.
  • Kopp Investment Advisors's ten largest holdings make up 46% of its $119M portfolio in Q3 2018.
  • Kopp Investment Advisors opened 3 new positions and closed 4 in Q3 2018.
  • Kopp Investment Advisors's portfolio value rose 11% quarter-over-quarter to $119M.

Based on Kopp Investment Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.